The Relationship Between Vulvovaginal Candidiasis and Provoked Vulvodynia: A Systematic Review

被引:17
|
作者
Leusink, Peter [1 ]
van de Pasch, Suzanne [1 ]
Teunissen, Doreth [1 ]
Laan, Ellen T. [2 ]
Lagro-Janssen, Antoine L. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Primary & Community Care, Unit Gender & Womens Hlth, Med Ctr, POB 9101-118, NL-6500 HB Nijmegen, Netherlands
[2] Univ Amsterdam, Dept Sexol & Psychosomat Obstet & Gynaecol, Acad Med Ctr, Amsterdam, Netherlands
来源
JOURNAL OF SEXUAL MEDICINE | 2018年 / 15卷 / 09期
关键词
Vulvodynia; Vulvovaginal Candidiasis; Review; Dyspareunia; Sexual Dysfunction; Female; Women; Chronic Pain; Provoked Vulvodynia; Systematic Review; INTERLEUKIN-1 RECEPTOR ANTAGONIST; VESTIBULITIS SYNDROME; RISK-FACTORS; HUMAN-PAPILLOMAVIRUS; ORAL-CONTRACEPTIVES; CLINICAL-DIAGNOSIS; ISSVD TERMINOLOGY; WOMEN; VESTIBULODYNIA; PAIN;
D O I
10.1016/j.jsxm.2018.07.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Provoked vulvodynia (PVD) is a chronic vulvar pain condition affecting up to 8.3% of the female population. Despite many years of research, no clear cause for PVD has been identified. Several risk factors have been studied, including vulvovaginal candidiasis (VVC). However, to date, the role of Candida infections in PVD has remained unclear. VVC and PVD have an overlap of symptoms that may contribute to diagnostic inaccuracy and mistreatment. Aim: To systematically review the literature on the relationship between VVC and PVD. Methods: Cohort and case-control studies were included that compared women with PVD with healthy controls with respect to the presence of a history of Candida vulvovaginitis. PVD had to be diagnosed by Friedrich's criteria or the International Society for the Study of Vulvovaginal Disease criteria. The inclusion process as well as the quality appraisal of the studies, using the Newcastle-Ottawa Quality Assessment Scale, were performed independently by 2 authors. Main Outcome Measure: Outcomes of the population-based case-control studies were listed as odds ratio. Outcomes of the pathophysiological studies were based on local pro-inflammatory responses on Candida in vitro. Results: We included a total of 14 studies, both population and clinic-based case-control, and pathophysiological research. 7 studies were of low methodological quality, and 7 studies were of medium methodological quality. The population-based case-control studies showed a significantly increased odds ratio for self-reported VVC in PVD cases compared with controls. The pathophysiological studies revealed a tendency for an increased local proinflammatory response on Candida in vitro in patients with PVD. Owing to the substantial heterogeneity of the studies, meta-analysis was not performed. Clinical Implications: Health care providers may consider a diagnosis of PVD in women with self-reported VVC, and to act on this properly. Reiteration of antifungal prescriptions by physicians without a decent diagnosis, will lead to mistreatment. Women should be informed by their health care provider that intercourse during (or shortly after) the treatment of VVC might worsen the vulnerability of the vulvar skin. Strength and Limitations: This is the first systematic review performed to describe the relation between VVC and PVD. An independently performed in-and exclusion process and quality appraisal, ensured optimal internal validity. However, there were important methodological limitations and the size of heterogeneity prevented establishing a meta-analysis. Conclusion: This systematic review is unable to draw conclusions regarding a relationship between actual VVC and PVD because studies were based on self-reported VVC. Until new evidence becomes available, we advocate that PVD should be considered as an unexplained chronic pain condition. In women with recurrent or persistent VVC-like complaints, physicians should consider a diagnosis of PVD. Copyright (C) 2018, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1310 / 1321
页数:12
相关论文
共 50 条
  • [21] Recurrent vulvovaginal candidiasis: A review of guideline recommendations
    Matheson, Alexia
    Mazza, Danielle
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 (02): : 139 - 145
  • [22] Probiotics for prevention of recurrent vulvovaginal candidiasis: a review
    Falagas, Matthew E.
    Betsi, Gregoria I.
    Athanasiou, Stavros
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 266 - 272
  • [23] Effectiveness of redcore lotion in patients with vulvovaginal candidiasis: a systematic review and Meta-analysis
    DING Lijuan
    YIN Lu
    WANG Liping
    SUN Yaya
    LIU Xiaoyun
    LI Xiangrong
    [J]. Journal of Traditional Chinese Medicine, 2022, (04) : 487 - 492
  • [24] Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
    Rosa, Maria I.
    Silva, Bruno R.
    Pires, Patricia S.
    Silva, Fabio R.
    Silva, Napoleao C.
    Silva, Fabio R.
    Souza, Sueli L.
    Madeira, Kristian
    Panatto, Ana P.
    Medeiros, Lidia R.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 167 (02) : 132 - 136
  • [25] Effectiveness of redcore lotion in patients with vulvovaginal candidiasis: a systematic review and Meta-analysis
    Ding Lijuan
    Yin Lu
    Wang Liping
    Sun Yaya
    Liu Xiaoyun
    Li Xiangrong
    [J]. JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2022, 42 (04) : 487 - 492
  • [26] Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) - A systematic review and meta-analysis
    Siddiqui, Tasmiyah
    Kumar, Kanwal Ashok
    Iqbal, Amna
    Doultani, Payal Rani
    Ashraf, Tayyaba
    Eqbal, Farea
    Siddiqui, Samrah Inam
    [J]. HELIYON, 2023, 9 (11)
  • [27] Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis: A Drug Review
    Lanier, Cameron
    Melton, Tyler C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (06) : 636 - 644
  • [28] Prevalence of vulvovaginal candidiasis among pregnant women in Africa: A systematic review and meta-analysis
    Mohamed, Ahmed Osman
    Mohamed, Malik Suliman
    Mallhi, Tauqeer Hussain
    Hussain, Mohamed Abdelrahman
    Jalloh, Mohammad Ali
    Omar, Khatib Ali
    Alhaj, Manasik Omar
    Ali, Alaa Aldeen Makki Mohamed
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (08): : 1243 - +
  • [29] Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
    Lirio, Juliana
    Giraldo, Paulo Cesar
    Sarmento, Ayane Cristine
    Costa, Ana Paula Ferreira
    Cobucci, Ricardo Ney
    Saconato, Humberto
    Junior, Jose Eleuterio
    Goncalves, Ana Katherine
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (02): : 261 - 267
  • [30] Beyond fluconazole: A review of vulvovaginal candidiasis diagnosis and treatment
    Hellier, Susan D.
    Wrynn, Alexander F.
    [J]. NURSE PRACTITIONER, 2023, 48 (09): : 33 - 39